A phase I study of AZD9496, a novel oral, selective estrogen receptor degrader (SERD) in women with estrogen receptor positive, HER-2 negative advanced breast cancer (ABC) Meeting Abstract
| Authors: | Hamilton, E.; Patel, M.; Armstrong, A.; Baird, R.; Jhaveri, K.; Hoch, M.; Morgan, S.; Dowdall, T.; Schiavon, G.; Klinowska, T.; Weir, H.; Bujac, S.; Nash, T.; Im, S. A. |
| Abstract Title: | A phase I study of AZD9496, a novel oral, selective estrogen receptor degrader (SERD) in women with estrogen receptor positive, HER-2 negative advanced breast cancer (ABC) |
| Meeting Title: | 2016 San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 77 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2016 Dec 6-10 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2017-02-01 |
| Language: | English |
| ACCESSION: | WOS:000397999002316 |
| DOI: | 10.1158/1538-7445.sabcs16-p6-12-03 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P6-12-03 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work